Showing results (2201-2210 of 2,809) with videos related to

Sort By:
Pageof 281
Cytotherapy|September 23, 2022
Weight gain during treatment course of allogenic hematopoietic stem cell transplantation in patients with hematological malignancies affects treatment outcomeSilje Johansen, Bjørn Blomberg, Anh Khoi Vo, et al.
Cytotherapy|May 31, 2011
Monitoring human mesenchymal stromal cell differentiation by electrochemical impedance sensingMichael Angstmann, Irena Brinkmann, Karen Bieback, et al.
Cytotherapy|September 9, 2015
Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantationChun K K Ma, Emily Blyth, Leighton Clancy, et al.
Cytotherapy|January 17, 2015
Cryopreservation does not alter main characteristics of Good Manufacturing Process-grade human multipotent mesenchymal stromal cells including immunomodulating potential and lack of malignant transformationJana Luetzkendorf, Katrin Nerger, Julian Hering, et al.
Cytotherapy|September 6, 2015
Autologous transplantation of mesenchymal stromal cells tends to prevent progress of interstitial fibrosis in a rhesus Macaca mulatta monkey model of chronic kidney diseaseReza Moghadasali, Mostafa Hajinasrollah, Hassan Argani, et al.
Cytotherapy|August 11, 2015
Effects of human amnion-derived mesenchymal stromal cell transplantation in rats with radiation proctitisMasayoshi Ono, Shunsuke Ohnishi, Minori Honda, et al.
Cytotherapy|August 13, 2015
Mesenchymal stromal cells are genetically stable under a hostile in vivo-like scenario as revealed by in vitro micronucleus testShikha Sharma, Ramesh Bhonde
Cytotherapy|October 4, 2015
Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsetsHeng Li, Weiwei Wang, Guoyan Wang, et al.
Cytotherapy|December 27, 2015
T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G-opsonized target cellsMaria Michela D'Aloia, Sara Caratelli, Camilla Palumbo, et al.
Cytotherapy|November 22, 2015
The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cellsSeungok Lee, Byung-Joon Park, Ji Yeon Kim, et al.
Pageof 281